Industry News

Industry News

A Genetic Defect In Sex Cells May Predispose To Childhood Leukemia

Dec 21, 2012

Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children... Read More

Mayo Clinic Study Unmasks Regulator Of Healthy Life Span

Dec 21, 2012

A new series of studies in mouse models by Mayo Clinic researchers uncovered that the aging process is characterized by high rates of whole-chromosome losses and gains in various organs, including heart, muscle, kidney and eye, and demonstrate that reducing these rates slows age-related tissue deterioration and promotes a healthier life span... Read More

New Technology May Enable Earlier Cancer Diagnosis

Dec 21, 2012

Finding ways to diagnose cancer earlier could greatly improve the chances of survival for many patients. One way to do this is to look for specific proteins secreted by cancer cells, which circulate in the bloodstream. However, the quantity of these biomarkers is so low that detecting them has proven difficult... Read More

Improving Cell-Based Immune Therapies For Cancer

Dec 21, 2012

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer. Their findings were reported online in Nature Biotechnology... Read More

Scientists Find Gene Linked To Ovarian And Breast Cancer

Dec 21, 2012

Mutations in a gene known as PPM1D are associated with a higher risk of breast and ovarian cancer - which may represent a new cancer-causing process. The finding came from a new study published in the journal Nature which was conducted by a team of experts from The Institute of Cancer Research, London... Read More

New Molecule Linked To Late-Stage Breast Cancer Discovered

Dec 21, 2012

Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer - a discovery that could point the way to potential cures. Until this study, the ribonucleic acid (RNA) molecule called miR-181a had never before been tied to breast cancer metastasis... Read More

GSK Revolade® (Eltrombopag) Receives Provisional NICE Recommendation For Treatment Of Chronic ITP

Dec 21, 2012

Once-daily oral treatment offers patients a clinically and cost-effective option Patients in England and Wales living with an immune disorder causing low blood platelet count, known as " cITP", chronic immune (idiopathic) thrombocytopenic purpura, are one step closer to being able to access Revolade® (eltrombopag) on the National Health Service (NHS)... Read More

Scientists Find Gene Linked To Ovarian And Breast Cancer

Dec 21, 2012

Mutations in a gene known as PPM1D are associated with a higher risk of breast and ovarian cancer - which may represent a new cancer-causing process. The finding came from a new study published in the journal Nature which was conducted by a team of experts from The Institute of Cancer Research, London... Read More

A Genetic Defect In Sex Cells May Predispose To Childhood Leukemia

Dec 20, 2012

Rare atypical forms of the PRDM9 fertility gene found in parents Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children... Read More

Phase 2 Clinical Trial Of Ibrutinib Shows High Overall Response, Remissions In Patients With Resistant Mantle Cell Lymphoma

Dec 20, 2012

An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side effects. Researchers from The University of Texas MD Anderson Cancer Center presented interim findings of the multi-center Phase 2 study at the 54th American Society of Hematology Annual Meeting and Exposition... Read More

Previous Page   Next Page